New fees for claims appeals, paperwork rules for testing and time limits for certain services are novel ways to constrain ...

Analyst David Windley of Jefferies maintained a Buy rating on UnitedHealth (UNH – Research Report), reducing the price target to $609.00.Invest ...

CEO Andrew Witty promised that UnitedHealthcare would work to speed up turnaround times for approval of some procedures and ...

The UnitedHealth Group leader whose murder in December unleashed a torrent of public frustration and dissatisfaction with the U.S. health care system was pushing for some of the very improvements that ...

Wegovy, Ozempic added to list of drugs where the federal government will try winning discounts from manufacturers.

UnitedHealth Group (NYSE:UNH), a leading diversified healthcare company with a substantial market capitalization of $469.7 ...

Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...

UnitedHealth Q4 earnings beat EPS estimates at $6.81 but missed revenue projections. Analysts highlight growth potential in ...

As government scrutiny and enforcement targeting the Medicare Advantage (Medicare Part C) program continued in 2024, the ...

Analyst Joanna Gajuk of Bank of America Securities maintained a Buy rating on UnitedHealth (UNH – Research Report), reducing the price target ...

This value-based world in which we find ourselves living presents a fascinating paradox. At the same time that it promises to ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story UnitedHealth CEO blames drug companies ...